Hervé Isola

520 total citations
21 papers, 385 citations indexed

About

Hervé Isola is a scholar working on Biochemistry, Management of Technology and Innovation and Hematology. According to data from OpenAlex, Hervé Isola has authored 21 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biochemistry, 12 papers in Management of Technology and Innovation and 10 papers in Hematology. Recurrent topics in Hervé Isola's work include Blood transfusion and management (14 papers), Blood donation and transfusion practices (12 papers) and Blood groups and transfusion (6 papers). Hervé Isola is often cited by papers focused on Blood transfusion and management (14 papers), Blood donation and transfusion practices (12 papers) and Blood groups and transfusion (6 papers). Hervé Isola collaborates with scholars based in France, United States and Belgium. Hervé Isola's co-authors include Jean‐Pierre Cazenave, Daniel Kientz, Laurence Corash, Lily Lin, Christian Gachet, Catherine Ravanat, Michèle Jacquet, David J. Sundin, P L Simon and Anita Eckly and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Transfusion.

In The Last Decade

Hervé Isola

21 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hervé Isola France	9	206	157	122	106	55	21	385
V. Mayaudon United States	11	421 2.0×	261 1.7×	265 2.2×	29 0.3×	49 0.9×	13	565
Koo‐Whang Chung United States	7	264 1.3×	185 1.2×	125 1.0×	93 0.9×	116 2.1×	7	497
K. Morris Ireland	12	149 0.7×	112 0.7×	106 0.9×	30 0.3×	46 0.8×	18	325
John A.J. Barbara United Kingdom	12	75 0.4×	83 0.5×	76 0.6×	115 1.1×	28 0.5×	38	381
Patricia A. R. Brunker United States	9	41 0.2×	58 0.4×	92 0.8×	67 0.6×	35 0.6×	26	257
Frank Tolksdorf Germany	11	131 0.6×	99 0.6×	82 0.7×	182 1.7×	15 0.3×	14	458
Angelika Valentin Austria	7	27 0.1×	56 0.4×	80 0.7×	111 1.0×	9 0.2×	12	313
Aseem Kumar Tiwari India	10	51 0.2×	50 0.3×	124 1.0×	24 0.2×	11 0.2×	71	335
Julian B. Schorr United States	10	69 0.3×	84 0.5×	120 1.0×	97 0.9×	20 0.4×	17	385
Joanne Chiavetta Canada	7	107 0.5×	105 0.7×	33 0.3×	58 0.5×	40 0.7×	10	344

Countries citing papers authored by Hervé Isola

Since Specialization

Citations

This map shows the geographic impact of Hervé Isola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Isola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Isola more than expected).

Fields of papers citing papers by Hervé Isola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Isola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Isola. The network helps show where Hervé Isola may publish in the future.

Co-authorship network of co-authors of Hervé Isola

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Isola. A scholar is included among the top collaborators of Hervé Isola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Isola. Hervé Isola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brouard, Nathalie, Adeline Galvanin, Daniel Kientz, et al.. (2023). Biochemical and functional characteristics of stored (double‐dose) buffy‐coat platelet concentrates treated with amotosalen and a prototype UVA light‐emitting diode illuminator. Transfusion. 63(10). 1937–1950. 1 indexed citations

Girard, Yvette A., Lotfi Bounaadja, Jean‐Marc Payrat, et al.. (2022). Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction. Transfusion. 62(5). 1073–1083. 5 indexed citations

Isola, Hervé, Catherine Ravanat, Floriane Rudwill, et al.. (2021). Removal of citrate from PAS‐III additive solution improves functional and biochemical characteristics of buffy‐coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction. Transfusion. 61(3). 919–930. 13 indexed citations

Ravanat, Catherine, Monique Freund, Floriane Rudwill, et al.. (2021). Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the murine circulation: A promising approach to monitor platelet survival in vivo in clinical research. Transfusion. 61(5). 1642–1653. 6 indexed citations

Ravanat, Catherine, Arnaud Dupuis, Guillaume Mourey, et al.. (2018). In vitro quality of amotosalen‐UVA pathogen‐inactivated mini‐pool plasma prepared from whole blood stored overnight. Vox Sanguinis. 113(7). 622–631. 5 indexed citations

Kientz, Daniel, Catherine Humbrecht, Hervé Isola, & Christian Gachet. (2018). Adaptation de la délivrance des concentrés plaquettaires aux recommandations HAS/ANSM 2015 à l’EFS Grand-Est. Transfusion Clinique et Biologique. 25(3). 187–191. 1 indexed citations

Ohlmann, Philippe, Béatrice Hechler, Philippe Chafey, et al.. (2016). Hemostatic properties and protein expression profile of therapeutic apheresis plasma treated with amotosalen and ultraviolet A for pathogen inactivation. Transfusion. 56(9). 2239–2247. 3 indexed citations

Griensven, Johan van, Anja De Weggheleire, Alexandre Délamou, et al.. (2015). The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field. Clinical Infectious Diseases. 62(1). 69–74. 71 indexed citations

Isola, Hervé, et al.. (2012). Conduite à tenir en cas d’effet indésirable receveur à l’établissement français du sang. Transfusion Clinique et Biologique. 19(4-5). 182–186. 1 indexed citations

10.

Hechler, Béatrice, Philippe Ohlmann, Philippe Chafey, et al.. (2012). Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation. Transfusion. 53(6). 1187–1200. 49 indexed citations

11.

Cazenave, Jean‐Pierre, et al.. (2010). Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3‐year period. Transfusion. 51(3). 622–629. 64 indexed citations

12.

Isola, Hervé, et al.. (2010). La gestion des informations post-don : un élément fondamental de la sécurité transfusionnelle. Transfusion Clinique et Biologique. 17(5-6). 296–300. 6 indexed citations

13.

Simon, P L, Hervé Isola, Daniel Kientz, et al.. (2009). Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion. Transfusion. 49(6). 1083–1091. 90 indexed citations

14.

Isola, Hervé, et al.. (2009). Évolution des techniques de préparation des produits sanguins labiles (PSL) : inactivation des pathogènes dans les PSL. Transfusion Clinique et Biologique. 16(2). 179–189. 10 indexed citations

15.

Schlenke, Peter, Tor Hervig, Hervé Isola, et al.. (2008). Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers. Transfusion. 48(4). 697–705. 37 indexed citations

16.

Cazenave, Jean‐Pierre, Philippe Ohlmann, Hervé Isola, & Christian Gachet. (2008). Photochemical Pathogen Inactivation Treatment of Human Plasma (amotosalen + UVA) Has No Major Impact on the Protein expression pattern Assessed by a 2-DIGE Proteomic Assay.. Blood. 112(11). 1994–1994. 2 indexed citations

17.

Cazenave, Jean‐Pierre, Simone Schuhler, Catherine Ravanat, et al.. (2007). Retention of Thrombin Generation Capacity of Therapeutic Apheresis Plasma Prepared with Amotosalen and UVA Light (INTERCEPT) Pathogen Inactivation.. Blood. 110(11). 4027–4027. 1 indexed citations

18.

Isola, Hervé, Daniel Kientz, Boris Aleil, et al.. (2005). In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set. Vox Sanguinis. 90(2). 128–130. 9 indexed citations

19.

Cazenave, Jean‐Pierre, Hervé Isola, Christian Gachet, & Boris Aleil. (2005). Actualités en transfusion sur la conservation des plaquettes. Transfusion Clinique et Biologique. 12(2). 226–229. 2 indexed citations

20.

Kientz, Daniel, et al.. (2001). Leukodepletion of platelet concentrates and plasma collected with haemonetics MCS+ apheresis system. Experience of EFS-Alsace. Transfusion and Apheresis Science. 25(1). 55–59. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact